{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:28:30Z","timestamp":1793021310907,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05433-w","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:46:53Z","timestamp":1770436013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The beneficial effects of Chlorella vulgaris supplementation on health-related indices in patients with non-alcoholic fatty liver disease: a GRADE-assessed systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7343-027X","authenticated-orcid":false,"given":"Ali","family":"Jafari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helia","family":"Mardani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahare Parsi","family":"Nezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1944-0052","authenticated-orcid":false,"given":"Azita","family":"Hekmatdoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"47","key":"5433_CR1","doi-asserted-by":"publisher","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","volume":"23","author":"BJ Perumpail","year":"2017","unstructured":"Perumpail BJ, Khan MA, Yoo ER, Cholankeril G, Kim D, Ahmed A. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J Gastroenterol. 2017;23(47):8263.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"5433_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"6","key":"5433_CR3","doi-asserted-by":"publisher","first-page":"100706","DOI":"10.1016\/j.aohep.2022.100706","volume":"27","author":"YAO Rojas","year":"2022","unstructured":"Rojas YAO, Cuellar CLV, Barr\u00f3n KMA, Arab JP, Miranda AL. Non-alcoholic fatty liver disease prevalence in Latin america: A systematic review and meta-analysis. Ann Hepatol. 2022;27(6):100706.","journal-title":"Ann Hepatol"},{"issue":"7","key":"5433_CR4","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/HYPERTENSIONAHA.122.17982","volume":"79","author":"E Muzurovi\u0107","year":"2022","unstructured":"Muzurovi\u0107 E, Peng CC-H, Belanger MJ, Sanoudou D, Mikhailidis DP, Mantzoros CS. Nonalcoholic fatty liver disease and cardiovascular disease: a review of shared cardiometabolic risk factors. Hypertension. 2022;79(7):1319\u201326.","journal-title":"Hypertension"},{"key":"5433_CR5","doi-asserted-by":"crossref","unstructured":"Duell PB, Welty FK, Miller M, Chait A, Hammond G, Ahmad Z et al. Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American heart Association. Arteriosclerosis, thrombosis, and vascular biology. 2022;42(6):e168\u201385.","DOI":"10.1161\/ATV.0000000000000153"},{"key":"5433_CR6","doi-asserted-by":"crossref","unstructured":"Jafari A, Mardani H, Abbastabar M, Mehdipoor F, Nezhad BP, Kordkatuli K, et al. The effect of ginseng supplementation on CVD risk factors: a comprehensive systematic review and dose\u2013response meta-analysis. Br J Nutr. 2025;14:1\u201349.","DOI":"10.1136\/bmjopen-2023-080926"},{"issue":"22","key":"5433_CR7","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.3390\/nu15224829","volume":"15","author":"C Far\u00edas","year":"2023","unstructured":"Far\u00edas C, Cisternas C, Gana JC, Alberti G, Echeverr\u00eda F, Videla LA, et al. Dietary and nutritional interventions in nonalcoholic fatty liver disease in pediatrics. Nutrients. 2023;15(22):4829.","journal-title":"Nutrients"},{"issue":"12","key":"5433_CR8","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.3390\/nu12123860","volume":"12","author":"M Parra-Vargas","year":"2020","unstructured":"Parra-Vargas M, Rodriguez-Echevarria R, Jimenez-Chillaron JC. Nutritional approaches for the management of nonalcoholic fatty liver disease: an evidence-based review. Nutrients. 2020;12(12):3860.","journal-title":"Nutrients"},{"key":"5433_CR9","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.5646\/ch.2025.31.e33","volume":"31","author":"H Mardani","year":"2025","unstructured":"Mardani H, Ghalichi F, Fashtali ZM, Ardakany SJ, Yousefabady MA, Mohajerani A, et al. Sesame and cardiovascular balance: a GRADE-assessed systematic review and meta-analysis of its role in modulating risk factors among individuals with prehypertension and hypertension. Clin Hypertens. 2025;31:e33.","journal-title":"Clin Hypertens"},{"issue":"9","key":"5433_CR10","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3390\/nu12092524","volume":"12","author":"T Bito","year":"2020","unstructured":"Bito T, Okumura E, Fujishima M, Watanabe F. Potential of chlorella as a dietary supplement to promote human health. Nutrients. 2020;12(9):2524.","journal-title":"Nutrients"},{"issue":"2","key":"5433_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/1381612822666151112145226","volume":"22","author":"Y Panahi","year":"2016","unstructured":"Panahi Y, Darvishi B, Jowzi N, Beiraghdar F, Sahebkar A. Chlorella vulgaris: a multifunctional dietary supplement with diverse medicinal properties. Curr Pharm Design. 2016;22(2):164\u201373.","journal-title":"Curr Pharm Design"},{"key":"5433_CR12","doi-asserted-by":"publisher","first-page":"114624","DOI":"10.1016\/j.biopha.2023.114624","volume":"162","author":"H Barghchi","year":"2023","unstructured":"Barghchi H, Dehnavi Z, Nattagh-Eshtivani E, Alwaily ER, Almulla AF, Kareem AK, et al. The effects of chlorella vulgaris on cardiovascular risk factors: a comprehensive review on putative molecular mechanisms. Biomed Pharmacother. 2023;162:114624.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5433_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.7762\/cnr.2021.10.1.83","volume":"10","author":"S Yarmohammadi","year":"2021","unstructured":"Yarmohammadi S, Hosseini-Ghatar R, Foshati S, Moradi M, Hemati N, Moradi S, et al. Effect of chlorella vulgaris on liver function biomarkers: a systematic review and meta-analysis. Clin Nutr Res. 2021;10(1):83.","journal-title":"Clin Nutr Res"},{"key":"5433_CR14","doi-asserted-by":"publisher","first-page":"102822","DOI":"10.1016\/j.ctim.2022.102822","volume":"66","author":"N Sherafati","year":"2022","unstructured":"Sherafati N, Bideshki MV, Behzadi M, Mobarak S, Asadi M, Sadeghi O. Effect of supplementation with chlorella vulgaris on lipid profile in adults: A systematic review and dose-response meta-analysis of randomized controlled trials. Complement Ther Med. 2022;66:102822.","journal-title":"Complement Ther Med"},{"issue":"4","key":"5433_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1515\/jcim-2021-0024","volume":"19","author":"M Sanayei","year":"2022","unstructured":"Sanayei M, Kalejahi P, Mahinkazemi M, Fathifar Z, Barzegar A. The effect of chlorella vulgaris on obesity related metabolic disorders: a systematic review of randomized controlled trials. J Complement Integr Med. 2022;19(4):833\u201342.","journal-title":"J Complement Integr Med"},{"issue":"4","key":"5433_CR16","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1080\/15569543.2019.1700525","volume":"40","author":"R Mohseni","year":"2021","unstructured":"Mohseni R, Arab Sadeghabadi Z, Karimi J, Gholami H, Ghasemi H, Ghadimipour HR, et al. Chlorella vulgaris supplementation attenuates the progression of liver fibrosis through targeting TGF-\u03b2-signaling pathway in the CCl4-induced liver fibrosis in rats. Toxin Reviews. 2021;40(4):1347\u201355.","journal-title":"Toxin Reviews"},{"key":"5433_CR17","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372. https:\/\/www.bmj.com\/content\/372\/bmj.n71.short.","DOI":"10.1136\/bmj.n71"},{"issue":"112","key":"5433_CR18","first-page":"113","volume":"24","author":"S Aliashrafi","year":"2014","unstructured":"Aliashrafi S, Ebrahimi Mameghani M, Kakaie F, Javadzadeh Y, Asghari Jafarabadi M. The effect of microalgae chlorella vulgaris supplementation on inflammatory factors in non-alcoholic fatty liver disease (NAFLD): a double-blind randomized clinical trial. J Mazandaran Univ Med Sci. 2014;24(112):113\u201321.","journal-title":"J Mazandaran Univ Med Sci"},{"key":"5433_CR19","unstructured":"Chitsaz M, Mozaffari-Khosravi H, Salman-Roghani H, Zavar-Reza J, Lotfi M. Effect of Chlorella vulgaris vs. spirulina supplementation on lipid profile and liver function in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Int J Probiotics Prebiotics. 2016;11. https:\/\/openurl.ebsco.com\/openurl?sid=ebsco:plink:scholar&id=ebsco:gcd:120595539&crl=c."},{"issue":"1","key":"5433_CR20","first-page":"107","volume":"4","author":"M Ebrahimi-Mameghani","year":"2014","unstructured":"Ebrahimi-Mameghani M, Aliashrafi S, Javadzadeh Y, AsghariJafarabadi M. The effect of chlorella vulgaris supplementation on liver enzymes, serum glucose and lipid profile in patients with non-alcoholic fatty liver disease. Health Promotion Perspect. 2014;4(1):107.","journal-title":"Health Promotion Perspect"},{"issue":"105","key":"5433_CR21","first-page":"9","volume":"23","author":"M Ebrahimi-Mameghani","year":"2013","unstructured":"Ebrahimi-Mameghani M, Aliashrafi S, Khoshbaten M, Allahverdi Mamaghani B. The effect of microalgae chlorella vulgaris supplementation on lipid profile and lipid peroxidation in non-alcoholic fatty liver disease: a double-blind randomized clinical trial. J Mazandaran Univ Med Sci. 2013;23(105):9\u201318.","journal-title":"J Mazandaran Univ Med Sci"},{"issue":"4","key":"5433_CR22","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.clnu.2016.07.004","volume":"36","author":"M Ebrahimi-Mameghani","year":"2017","unstructured":"Ebrahimi-Mameghani M, Sadeghi Z, Farhangi MA, Vaghef-Mehrabany E, Aliashrafi S. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: beneficial effects of supplementation with microalgae chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial. Clin Nutr. 2017;36(4):1001\u20136.","journal-title":"Clin Nutr"},{"issue":"119","key":"5433_CR23","first-page":"2099","volume":"59","author":"Y Panahi","year":"2012","unstructured":"Panahi Y, Ghamarchehreh ME, Beiraghdar F, Zare R, Jalalian HR, Sahebkar A. Investigation of the effects of chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial. Hepatogastroenterology. 2012;59(119):2099\u2013103.","journal-title":"Hepatogastroenterology"},{"issue":"100","key":"5433_CR24","first-page":"36","volume":"23","author":"B Talebi Pour","year":"2015","unstructured":"Talebi Pour B, Jameshorani M, Salmani R. The effect of chlorella vulgaris vs. Artichoke on patients with non-alcoholic fatty liver disease (NAFLD): a randomized clinical trial. J Adv Med Biomedical Res. 2015;23(100):36\u201344.","journal-title":"J Adv Med Biomedical Res"},{"issue":"119","key":"5433_CR25","first-page":"2099","volume":"59","author":"Y Panahi","year":"2012","unstructured":"Panahi Y, Ghamarchehreh ME, Beiraghdar F, Zare M, Jalalian HR, Sahebkar A. Investigation of the effects of chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial. Hepatogastroenterology. 2012;59(119):2099\u2013103.","journal-title":"Hepatogastroenterology"},{"key":"5433_CR26","doi-asserted-by":"crossref","unstructured":"Fallah AA, Sarmast E, Habibian Dehkordi S, Engardeh J, Mahmoodnia L, Khaledifar A et al. Effect of chlorella supplementation on cardiovascular risk factors: A meta-analysis of randomized controlled trials. Clin Nutr. 2018;37(6, Part A):1892\u2009\u2013\u2009901.","DOI":"10.1016\/j.clnu.2017.09.019"},{"key":"5433_CR27","doi-asserted-by":"publisher","first-page":"592373","DOI":"10.3389\/fendo.2020.592373","volume":"11","author":"MV Chakravarthy","year":"2020","unstructured":"Chakravarthy MV, Siddiqui MS, Forsgren MF, Sanyal AJ. Harnessing Muscle-Liver crosstalk to treat nonalcoholic steatohepatitis. Front Endocrinol (Lausanne). 2020;11:592373.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"5433_CR28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3748\/wjg.v19.i7.1085","volume":"19","author":"J Azocar","year":"2013","unstructured":"Azocar J, Diaz A. Efficacy and safety of chlorella supplementation in adults with chronic hepatitis C virus infection. World J Gastroenterol. 2013;19(7):1085\u201390.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"5433_CR29","doi-asserted-by":"publisher","first-page":"26087","DOI":"10.3390\/ijms161125942","volume":"16","author":"S Li","year":"2015","unstructured":"Li S, Tan H-Y, Wang N, Zhang Z-J, Lao L, Wong C-W, et al. The role of oxidative stress and antioxidants in liver diseases. Int J Mol Sci. 2015;16(11):26087\u2013124.","journal-title":"Int J Mol Sci"},{"key":"5433_CR30","doi-asserted-by":"crossref","unstructured":"Kumashiro N, Erion DM, Zhang D, Kahn M, Beddow SA, Chu X et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proceedings of the National Academy of Sciences. 2011;108(39):16381-5.","DOI":"10.1073\/pnas.1113359108"},{"issue":"1","key":"5433_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lfs.2013.11.020","volume":"95","author":"JF Vecina","year":"2014","unstructured":"Vecina JF, Oliveira AG, Araujo TG, Baggio SR, Torello CO, Saad MJ, et al. Chlorella modulates insulin signaling pathway and prevents high-fat diet-induced insulin resistance in mice. Life Sci. 2014;95(1):45\u201352.","journal-title":"Life Sci"},{"issue":"4","key":"5433_CR32","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1271\/bbb.60566","volume":"71","author":"S Shibata","year":"2007","unstructured":"Shibata S, Hayakawa K, Egashira Y, Sanada H. Hypocholesterolemic mechanism of chlorella: chlorella and its indigestible fraction enhance hepatic cholesterol catabolism through up-regulation of cholesterol 7alpha-hydroxylase in rats. Biosci Biotechnol Biochem. 2007;71(4):916\u201325.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"3","key":"5433_CR33","first-page":"79","volume":"7","author":"RE Merchant","year":"2001","unstructured":"Merchant RE, Andre CA. A review of recent clinical trials of the nutritional supplement chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis. Altern Ther Health Med. 2001;7(3):79\u201392.","journal-title":"Altern Ther Health Med"},{"issue":"1","key":"5433_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1475-2891-10-91","volume":"10","author":"T Otsuki","year":"2011","unstructured":"Otsuki T, Shimizu K, Iemitsu M, Kono I. Salivary secretory Immunoglobulin A secretion increases after 4-weeks ingestion of chlorella-derived multicomponent supplement in humans: a randomized cross over study. Nutr J. 2011;10(1):91.","journal-title":"Nutr J"},{"issue":"12","key":"5433_CR35","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1111\/j.1572-0241.2002.07145.x","volume":"97","author":"M Iwasa","year":"2002","unstructured":"Iwasa M, Yamamoto M, Tanaka Y, Kaito M, Adachi Y. Spirulina-associated hepatotoxicity. Official J Am Coll Gastroenterology| ACG. 2002;97(12):3212\u20133.","journal-title":"Official J Am Coll Gastroenterology| ACG"},{"issue":"2","key":"5433_CR36","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s10811-016-0974-5","volume":"29","author":"ML Wells","year":"2017","unstructured":"Wells ML, Potin P, Craigie JS, Raven JA, Merchant SS, Helliwell KE, et al. Algae as nutritional and functional food sources: revisiting our Understanding. J Appl Phycol. 2017;29(2):949\u201382.","journal-title":"J Appl Phycol"},{"issue":"6","key":"5433_CR37","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3390\/nu17060943","volume":"17","author":"M Pinto-Leite","year":"2025","unstructured":"Pinto-Leite M, Martins D, Ferreira AC, Silva C, Trindade F, Saraiva F, et al. The role of chlorella and spirulina as adjuvants of cardiovascular risk factor control: A systematic review and Meta-Analysis of randomised controlled trials. Nutrients. 2025;17(6):943.","journal-title":"Nutrients"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05433-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05433-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05433-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:59:28Z","timestamp":1773226768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-025-05433-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5433"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05433-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As a systematic review and meta-analysis, our manuscript did not necessitate any referral for review to our institutional clinical ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"221"}}